Helen Arthur

Dr. Helen Arthur


Research Focus & Metrics

Academic Career Length

75Years (1952-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2007 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
PDPeter Ten Dijke
Peter Ten Dijke
HAHelen Arthur
Helen Arthur

23 September 2004 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
FLFrank Lebrin
Frank Lebrin
MGMarie-José Goumans
Marie-José Goumans
LJLeon Jonker
Leon Jonker
RCRita Lc Carvalho
Rita Lc Carvalho
GVGudrun Valdimarsdottir
Gudrun Valdimarsdottir
PDPeter Ten Dijke
Peter Ten Dijke
Endoglin is a transmembrane accessory receptor for transforming growth factor‐β (TGF‐β) that is predominantly expressed on proliferating endothelial cells in culture and on angiogenic blood vessels in vivo . Endoglin, as well as other TGF‐β signalling components, is essential during angiogenesis. Mutations in endoglin and activin receptor‐like kinase 1 (ALK1), an endothelial specific TGF‐β type I receptor, have been linked to the vascular disorder, hereditary haemorrhagic telangiectasia. However, the function of endoglin in TGF‐β/ALK signalling has remained unclear. Here we report that endoglin is required for efficient TGF‐β/ALK1 signalling, which indirectly inhibits TGF‐β/ALK5 signalling. Endothelial cells lacking endoglin do not grow because TGF‐β/ALK1 signalling is reduced and TGF‐β/ALK5 signalling is increased. Surviving cells adapt to this imbalance by downregulating ALK5 expression in order to proliferate. The ability of endoglin to promote ALK1 signalling also explains why ectopic endoglin expression in endothelial cells promotes proliferation and blocks TGF‐β‐induced growth arrest by indirectly reducing TGF‐β/ALK5 signalling. Our results indicate a pivotal role for endoglin in the balance of ALK1 and ALK5 signalling to regulate endothelial cell proliferation.

17 July 2013 in Nature
Verified
Journal Article
Open access
PDF file
XWXiaomeng Wang
Xiaomeng Wang
SASabu Abraham
Sabu Abraham
JMJenny A. G. McKenzie
Jenny A. G. McKenzie
NJNatasha Jeffs
Natasha Jeffs
MSMatthew Swire
Matthew Swire
John GreenwoodJohn Greenwood
John Greenwood
Aberrant neovascularization contributes to diseases such as cancer, blindness and atherosclerosis, and is the consequence of inappropriate angiogenic signalling. Although many regulators of pathogenic angiogenesis have been identified, our understanding of this process is incomplete. Here we explore the transcriptome of retinal microvessels isolated from mouse models of retinal disease that exhibit vascular pathology, and uncover an upregulated gene, leucine-rich alpha-2-glycoprotein 1 (Lrg1), of previously unknown function. We show that in the presence of transforming growth factor-β1 (TGF-β1), LRG1 is mitogenic to endothelial cells and promotes angiogenesis. Mice lacking Lrg1 develop a mild retinal vascular phenotype but exhibit a significant reduction in pathological ocular angiogenesis. LRG1 binds directly to the TGF-β accessory receptor endoglin, which, in the presence of TGF-β1, results in promotion of the pro-angiogenic Smad1/5/8 signalling pathway. LRG1 antibody blockade inhibits this switch and attenuates angiogenesis. These studies reveal a new regulator of angiogenesis that mediates its effect by modulating TGF-β signalling.

8 February 2019 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
RARhys Anderson
Rhys Anderson
ALAnthony Lagnado
Anthony Lagnado
DMDamien Maggiorani
Damien Maggiorani
AWAnna Walaszczyk
Anna Walaszczyk
EDEmily Dookun
Emily Dookun
JPJoão F Passos
João F Passos
Ageing is the biggest risk factor for cardiovascular disease. Cellular senescence, a process driven in part by telomere shortening, has been implicated in age‐related tissue dysfunction. Here, we address the question of how senescence is induced in rarely dividing/post‐mitotic cardiomyocytes and investigate whether clearance of senescent cells attenuates age‐related cardiac dysfunction. During ageing, human and murine cardiomyocytes acquire a senescent‐like phenotype characterised by persistent DNA damage at telomere regions that can be driven by mitochondrial dysfunction and crucially can occur independently of cell division and telomere length. Length‐independent telomere damage in cardiomyocytes activates the classical senescence‐inducing pathways, p21 CIP and p16 INK4a , and results in a non‐canonical senescence‐associated secretory phenotype, which is pro‐fibrotic and pro‐hypertrophic. Pharmacological or genetic clearance of senescent cells in mice alleviates detrimental features of cardiac ageing, including myocardial hypertrophy and fibrosis. Our data describe a mechanism by which senescence can occur and contribute to age‐related myocardial dysfunction and in the wider setting to ageing in post‐mitotic tissues.

1 January 2000 in Developmental Biology
Verified
Journal Article
Closed access
HAHelen Arthur
Helen Arthur
JUJan Ure
Jan Ure
ASAndrew J.H. Smith
Andrew J.H. Smith
GRGlenn Renforth
Glenn Renforth
DWDavid I. Wilson
David I. Wilson
ADAustin G. Diamond
Austin G. Diamond

17 November 2010 in In Vitro Cellular & Developmental Biology - Animal
Verified
Journal Article
Closed access
PDF file
SWSarah J. Watkins
Sarah J. Watkins
GBGillian M. Borthwick
Gillian M. Borthwick
HAHelen Arthur
Helen Arthur